This finding is in agreement with previous studies showing that in different cancer cells HDAC inhibitors curtail survivin expression by multiple mechanisms, including reduction of transcription, altered post-translational modification, and increased proteosomal degradation [33,34,35]. This evidence concerns the gene BIRC5 and cancer.